PT Merck Tbk (IDX:MERK)

PT Merck Tbk Revenue

PT Merck Tbk had revenue of 358.88B IDR in the quarter ending September 30, 2026, with 7.46% growth. This brings the company's total for the last twelve months to 1.38T, up 25.39% year-over-year. In the year 2025, PT Merck Tbk had annual revenue of 1.20T with 15.81% growth. That makes PT Merck Tbk the 24,842nd largest company in the world by revenue and 397th in Indonesia.

• Revenue (ttm): 1.38T
• Revenue Growth: +25.39%
• P/S Ratio: 1.18
• Revenue / Employee: 3.84B
• Employees: 358
• Market Cap: 1.62T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biopharma 710.11B 59.1%
• Consumer Health 490.55B 40.9%

By Geography

Chart

• Indonesia 918.65B 76.5%
• Offshore Countries 282.02B 23.5%

Fiscal year ended Dec 31, 2025 See the full PT Merck Tbk breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.20T	163.92B	15.81%
Dec 31, 2024	1.04T	75.31B	7.83%
Dec 31, 2023	961.43B	-163.17B	-14.51%
Dec 31, 2022	1.12T	60.20B	5.66%
Dec 31, 2021	1.06T	408.55B	62.29%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error